Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 12, 2024, after the close
10-Q filed Aug 12, 2024, 43 days after period end · 0000950170-24-095432
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$4.08M | -$3.39M | -$2.34M | -$31.75M |
| EPS Diluted | -$3.32 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$7.93 |
| -$5.77 |
| -$4.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
